Table 4.
Summary of aneusomy 17 in breast-cancer progression (combination of study results from table 3)
| Specimens (N)* | Disomy | Monosomy | Polysomy | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
||||||||
| NNR | N | %† | NNR | N | %† | NNR | N | %† | ||
| Proliferative lesion | 23 | 6 | 13 | 76 | 0 | 5 | 22 | 0 | 0 | 0 |
| Ductal carcinoma in situ | 32 | 24 | 2 | 25 | 3 | 10 | 34 | 0 | 16 | 50 |
| Lobular carcinoma in situ | 10 | 9 | 0 | 0 | 0 | 3 | 30 | 0 | 0 | 0 |
| Invasive carcinoma | 21 | 19 | 0 | 0 | 3 | 7 | 39 | 3 | 9 | 50 |
N=number of specimens. NR=not explicitly reported in reference.
*
Percent hybridisations from table 3 and associated tumours are not included.
†
Does not include NR specimens.